TAKEDA PHARMACEUTICAL CO LTD reported 1 transaction at OVID THERAPEUTICS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 12/9/2025ACC: 0001395064-25-000172
10% Owner
Since Feb 2019
+1.25M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
1.25M acquired · 1.25K disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+1.25M
Price / share
—
Trade value
—
% of position
21.7%
12/8/2025
5.75M→7M
Total
Net shares
+1.25M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 12/8/2025 | C · Conversion | +1.25M | — | — | 21.7% | 5.75M | 7M |
| Total | +1.25M | $0.00 | ||||||
Derivative Transactions1
Series A Convertible Preferred Stock
Indirect
Converts to
Common Stock
1.25K shares
Shares
−1.25K
Strike price
0
Held after
0.00
Exercisable
—
12/8/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Convertible Preferred Stock Indirect | Common Stock1.25K shares | 12/8/2025 | C · Conversion | −1.25K | 0 | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned1.78M
Total
1.78M direct1.78M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.78M | Direct |
| Total | 1.78M | 1.78M direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported